rs11627387 — MTHFD1
Intronic variant in the cytoplasmic trifunctional folate enzyme MTHFD1, associated with increased risk of congenital heart defects and neural tube defects — particularly under low dietary folate conditions
Details
- Gene
- MTHFD1
- Chromosome
- 14
- Risk allele
- A
- Clinical
- Risk Factor
- Evidence
- Moderate
Population Frequency
Category
Methylation & DetoxSee your personal result for MTHFD1
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
MTHFD1 rs11627387 — Folate Efficiency and Congenital Risk
MTHFD1 encodes the cytoplasmic trifunctional C1-tetrahydrofolate synthase11 cytoplasmic trifunctional C1-tetrahydrofolate synthase
a single protein
carrying three enzymatic domains: methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate
cyclohydrolase, and formyltetrahydrofolate synthetase
— three consecutive reactions that interconvert folate one-carbon carriers in the cytoplasm.
This central enzyme feeds activated one-carbon units into purine synthesis, thymidylate synthesis,
and the remethylation of homocysteine to methionine. rs11627387 is an intronic variant in strong
linkage disequilibrium with nearby functional variants on the same chromosome 14 haplotype, and
its A allele has been independently associated with congenital heart and neural tube defects in
case-control studies.
The Mechanism
The variant lies within intron 18 of MTHFD1 (GRCh38 chr14:64,457,258; NC_000014.9:g.64457258G>A).
As an intronic SNP, rs11627387 does not change the encoded protein sequence but is in
linkage disequilibrium with functional coding variants in the R653Q region22 linkage disequilibrium with functional coding variants in the R653Q region
rs2236225 encodes
the R653Q missense change; rs11627387 and rs2236224 are intronic tag SNPs on the same haplotype;
the Q allele impairs synthetase domain activity, meaning
it captures haplotype-level variation in MTHFD1 enzymatic output. When the synthetase domain is
impaired, the production of 10-formyl-THF (required for purine ring synthesis and thymidylate
synthesis) is reduced. During embryogenesis — when cells are dividing rapidly and nucleotide demand
is maximal — this bottleneck is most consequential.
The Evidence
Two independent case-control studies from the same research group establish the A allele's
association with birth defects. Zhu et al. 201233 Zhu et al. 2012
Gene variants in the folate-mediated
one-carbon metabolism pathway as risk factors for conotruncal heart defects. Am J Med Genet A,
2012 found the A allele conferred a 1.7-fold increase
in conotruncal heart defect risk in both Hispanic mothers (OR 1.7, 95% CI 1.1–2.5) and infants
(OR 1.7, 95% CI 1.2–2.3), suggesting both maternal folate metabolism and embryonic genotype contribute
independently. Etheredge et al. 201244 Etheredge et al. 2012
Maternal and infant gene-folate interactions and the risk
of neural tube defects. Am J Med Genet A, 2012 showed
that among infants with the A allele born to mothers with low folate intake, the odds ratio for
neural tube defects rose to 4.25 (80% CI 2.33–7.75) — the strongest gene-folate interaction
identified in that dataset. A 2022 study in Chinese children exposed to endemic fluoride found
GG homozygotes showed superior cognitive outcomes compared to AA carriers under high-fluoride
conditions (Feng et al. 2022, PMID 35838408)55 (Feng et al. 2022, PMID 35838408),
consistent with MTHFD1 influencing methylation-dependent neurodevelopment.
A meta-analysis of the closely linked rs2236225 (G1958A / R653Q) variant across 9 studies (4,302 NTD cases, 4,238 controls) found pooled OR 1.17 (p=0.001) for maternal carriers; Jiang et al. 201466 Jiang et al. 2014. Both rs11627387 and rs2236225 are on the same risk haplotype and should be interpreted together.
Practical Actions
The gene-folate interaction is the central actionable insight: the A allele's risk appears to be substantially modified by folate status. Women planning pregnancy who carry the A allele should prioritize preconception folate sufficiency using methylfolate (5-MTHF) rather than synthetic folic acid, which bypasses the conversion step. Choline is also relevant because the MTHFD1 pathway intersects with the choline-betaine methyl-donation route — impaired MTHFD1 increases dependence on choline for one-carbon unit supply.
Interactions
rs11627387 is in linkage disequilibrium with rs2236225 (MTHFD1 R653Q) and rs2236224 (intronic tag) — all three are on the same chromosome 14 risk haplotype. The functional variant is R653Q (rs2236225), which reduces the synthetase domain's stability via TRIM21-mediated ubiquitination. Interactions with MTHFR C677T (rs1801133) and MTR (rs1805087) are biologically plausible through convergent demand on the cytoplasmic folate pool, but no published study has quantified the combined rs11627387 + MTHFR effect directly. Compound MTHFR + MTHFD1 haplotype studies are warranted, especially for preconception counseling.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Standard MTHFD1 folate processing
You carry two copies of the G allele at rs11627387, the common reference genotype. This haplotype is associated with typical MTHFD1 trifunctional enzyme activity — normal cytoplasmic interconversion of folate one-carbon carriers supporting purine synthesis, thymidylate synthesis, and homocysteine remethylation. About 52% of people globally carry this genotype; it is most common in European and Latino populations.
Mildly reduced MTHFD1 haplotype efficiency; folate sufficiency is important
The A allele at rs11627387 tags a MTHFD1 haplotype that includes the functional R653Q missense change (rs2236225). R653Q reduces the protein stability of MTHFD1's synthetase domain, lowering 10-formylTHF production. In heterozygotes, one functional allele remains, so the impairment is partial. The strongest evidence for risk comes from studies examining embryonic outcomes under conditions of low maternal folate — the gene- nutrient interaction is the key finding, not the variant in isolation.
Homozygous MTHFD1 risk haplotype; folate and choline optimization are high priority
The AA homozygous state means both copies of chromosome 14 carry the risk haplotype, which tags the R653Q functional change in MTHFD1. Protein stability studies show R653Q causes TRIM21-mediated ubiquitination at K504, reducing the half-life of MTHFD1 protein and lowering 10-formylTHF production flux. This impairs purine synthesis and thymidylate supply during rapid cell division. In embryogenesis, this is particularly critical during neural tube closure (gestational days 21–28) and cardiac septation. The gene-folate interaction is the most actionable element: studies consistently show that adequate maternal folate intake substantially reduces the elevated risk associated with this genotype.
Outside of reproduction, the same pathway supports nucleotide synthesis in rapidly dividing adult tissues and methylation capacity. The 2022 cognitive study suggests that under environmental stressors (fluoride exposure), GG carriers showed better cognitive outcomes than AA carriers, pointing to a broader role of MTHFD1 haplotype in methylation-sensitive neurodevelopmental processes.